CIK 0001176309
- Non-accelerated filer
- Smaller reporting company
ORAMED PHARMACEUTICALS INC.
Sign in to watch- Ticker
- ORMP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 980376008
- Phone
- +1 646-844-1164
- Business address
- 1185 AVENUE OF THE AMERICAS, 3RD FLOOR, NEW YORK, NY, 10036
- Former names
- Integrated Security Technologies, Inc., IGUANA VENTURES LTD
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $225,530
- in 2 filings, $226K under 10b5-1 plans
Net −$225,530. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2012-08-22 | Sank Leonard Director | Grant or award · Warrant (right to buy) | +135,135 | $0.10 | $13K | 135,135 |
| 2012-08-08 | Zommer Yifat Hen CFO | Grant or award · Stock Option (right to buy) | +609,000 | 609,000 | ||
| 2012-08-08 | JACOB HAROLD Director | Grant or award · Stock Option (right to buy) | +240,000 | 240,000 | ||
| 2012-08-08 | Kidron Miriam Chief Technology Officer | Returned to the company · Warrant (right to buy) | −3,361,360 | 0 | ||
| 2012-08-08 | Kidron Miriam Chief Technology Officer | Grant or award · Warrant (right to buy) | +3,361,360 | 3,361,360 | ||
| 2012-08-08 | Berelowitz Michael Director | Grant or award · Stock Option (right to buy) | +40,000 | 340,000 | ||
| 2012-08-08 | Sank Leonard Director | Grant or award · Stock Option (right to buy) | +240,000 | 868,125 | ||
| 2012-08-08 | Zommer Yifat Hen CFO, TREASURER AND SECRETARY | Grant or award · Stock Option (right to buy) | +609,000 | 1,009,000 | ||
| 2012-08-08 | KIDRON NADAV President and CEO | Grant or award · Stock Option (right to buy) | +864,000 | 2,592,000 | ||
| 2012-08-08 | Kidron Miriam Chief Technology Officer | Grant or award · Stock Option (right to buy) | +864,000 | 5,953,360 | ||
| 2012-08-08 | JACOB HAROLD Director | Grant or award · Stock Option (right to buy) | +240,000 | 540,000 | ||
| 2011-10-04 | Sank Leonard Director | Purchase | +937,500 | $0.32 | $300K | 937,500 |
| 2011-10-04 | Sank Leonard Director | Grant or award · Warrant (right to buy) | +328,125 | 328,125 | ||
| 2011-09-27 | Bronfeld Zeev 10% owner | Sale | −350,000 | $0.28 | $98K | 5,808,517 |
| 2011-09-27 | Bronfeld Zeev 10% owner | Sale | −350,000 | $0.28 | $98K | 5,808,517 |
| 2011-03-31 | Bronfeld Zeev 10% owner | Purchase | +781,250 | $0.32 | $250K | 7,213,205 |
| 2011-03-31 | Bronfeld Zeev 10% owner | Other acquisition · Warrant | +273,438 | 273,438 | ||
| 2010-07-08 | Berelowitz Michael Director | Grant or award · Stock Option (right to buy) | +300,000 | 300,000 | ||
| 2010-04-21 | KIDRON NADAV CEO | Grant or award · Stock Option (right to buy) | +864,000 | 12,949,735 | ||
| 2010-04-21 | Kidron Miriam Chief Medical &Tech Officer | Grant or award · Stock Option (right to buy) | +864,000 | 5,939,360 |
Page 21 of 22 · 437 trades